INS and type 2 diabetes mellitus: The resultant immune activation, combined with reduced insulin sensitivity in adipocytes, promotes excessive release of free FAs, which in turn stimulate hepatic gluconeogenesis, ultimately contributing to hyperglycaemia and the progression of type 2 diabetes [156].